EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting regulatory T cell plasticity in gastric cancer: a unified bimodal model and precision immunotherapy paradigm: a hypothesis-generating review

PengFei Zhou, DanYa Wang, HaiYa Zhang, FengLin Zhang, ZhiTong Li, HongQing Xi

Frontiers in Oncology · 22.07.2026 · 16

DOI: 10.3389/fonc.2026.1882680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 22.07.2026. Verfasst von PengFei Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese People's Liberation Army (PLA), Beijing, China. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to other solid tumors, gastric cancer exhibits a particularly high dependence on regulatory T cell (Treg)-mediated immunosuppression. This reliance represents a critical driver of both primary and acquired resistance to programmed death-1/ligand-1(PD-1/PD-L1) inhibitors. By integrating existing single-cell, spatial transcriptomic, and clinical evidence, this review proposes a unified bimodal model of the Treg tumor microenvironment. Within this framework, the immune status in gastric cancer is determined by the dynamic equilibrium between immunosuppressive stable-type Tregs and pro-inflammatory fragile-type Tregs. H. pylori is posited as the master upstream regulator of this balance, capable of driving Treg differentiation toward either stability or fragility through temporally specific signaling pathways. Based on this framework, we introduce the Treg Stability-Fragility(Treg-SF) score, which incorporates Treg functional state, H. pylori infection status, and CD8 + T cell density as independently weighted variables within a unified model to predict immunotherapy efficacy. Furthermore, this review outlines three mechanism-based combination therapeutic strategies that target Treg plasticity, along with a detailed preclinical validation roadmap and risk–benefit analysis. These proposals provide an actionable translational roadmap to overcome Treg-mediated immune resistance and improve clinical outcomes in gastric cancer.

Schlagwörter

Stichwörter der Autor:innen

Treg cellfragile-like Treggastric cancerimmunotherapytumor microenvironment

Autor:innen und Institutionen

  • Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
  • Department of General Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Zitieren

APA

Zhou, P., Wang, D., Zhang, H., Zhang, F., Li, Z., & Xi, H. (2026). Targeting regulatory T cell plasticity in gastric cancer: a unified bimodal model and precision immunotherapy paradigm: a hypothesis-generating review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1882680

Vancouver

Zhou P, Wang D, Zhang H, Zhang F, Li Z, Xi H. Targeting regulatory T cell plasticity in gastric cancer: a unified bimodal model and precision immunotherapy paradigm: a hypothesis-generating review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1882680

BibTeX
@article{Zhou2026,
  author = {Zhou, PengFei and Wang, DanYa and Zhang, HaiYa and Zhang, FengLin and Li, ZhiTong and Xi, HongQing},
  title = {Targeting regulatory T cell plasticity in gastric cancer: a unified bimodal model and precision immunotherapy paradigm: a hypothesis-generating review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1882680}
}
Kostenlos starten →